Full-spectrum nonmetallic plasmonic carriers for efficient isopropanol dehydration.

Plasmonic hot carriers have the advantage of focusing, amplifying, and manipulating optical signals via electron oscillations which offers a feasible pathway to influence catalytic reactions. However, the contribution of nonmetallic hot carriers and thermal effects on the overall reactions are still unclear, and developing methods to enhance the efficiency of the catalysis is critical. Herein, we proposed a new strategy for flexibly modulating the hot electrons using a nonmetallic plasmonic heterostructure (named W18O49-nanowires/reduced-graphene-oxides) for isopropanol dehydration where the reaction rate was 180-fold greater than the corresponding thermocatalytic pathway. The key detail to this strategy lies in the synergetic utilization of ultraviolet light and visible-near-infrared light to enhance the hot electron generation and promote electron transfer for C-O bond cleavage during isopropanol dehydration reaction. This, in turn, results in a reduced reaction activation barrier down to 0.37 eV (compared to 1.0 eV of thermocatalysis) and a significantly improved conversion efficiency of 100% propylene from isopropanol. This work provides an additional strategy to modulate hot carrier of plasmonic semiconductors and helps guide the design of better catalytic materials and chemistries.

Influence of Sand-Cement Ratio and Polycarboxylate Superplasticizer on the Basic Properties of Mortar Based on Water Film Thickness.

Previous studies demonstrated that water film thickness (WFT) is a key factor that affects the fluidity of mortar. Changes in the sand-cement (S/C) ratio and polycarboxylate superplasticizer (PCE) dosage will affect the WFT. In this study, several mortar samples with different S/C ratios and different PCE dosages were prepared, and the basic properties of the mortar were measured. The results show that as the S/C ratio increases, the packing density of the mortar will decrease, the WFT will decrease, and the cohesiveness will increase, resulting in a decrease in the flow spread and strength of the mortar. When the PCE dosage is increased, the packing density of the mortar will increase, the WFT will increase, and the cohesiveness will decrease, which increases the flow spread of the mortar. When the water-cement (W/C) ratio is low, the S/C ratio has a significant effect on the strength, and the strength will increase with the increasing of the PCE dosage. When the W/C ratio is high, the strength of the mortar will be reduced once the PCE dosage exceeds the saturation value. In the case of different S/C ratios or different PCE dosages, the WFT can be used as a measure of mortar cohesiveness and flow spread.

Constructing Surface Plasmon Resonance on Bi2WO6 to Boost High-Selective CO2 Reduction for Methane.

Plasmonic Bi2WO6 with strong localized surface plasmon resonance (LSPR) around the 500-1400 region is successfully constructed by electron doping. Oxygen vacancies on W-O-W (V1) and Bi-O-Bi (V2) sites are precisely controlled to obtain Bi2WO6-V1 with LSPR and Bi2WO6-V2 with defect absorption. Density functional theory (DFT) calculation demonstrates that the V1-induced energy state facilitates photoelectron collection for a long lifetime, resulting in LSPR of Bi2WO6. Photoelectron trapping on V1 sites is demonstrated by a single-particle photoluminescence (PL) study, and 93% PL quenching efficiency is observed. With strong LSPR, plasmonic Bi2WO6-V1 exhibits highly selective methane generation with a rate of 9.95 µmol g-1 h-1 during the CO2 reduction reaction (CO2-RR), which is 26-fold higher than 0.37 µmol g-1 h-1 of BiWO3-V2 under UV-visible light irradiation. LSPR-dependent methane generation is confirmed by various photocatalytic results of plasmonic Bi2WO6 with tunable LSPR and different light excitations. Furthermore, the DFT-simulated pathway of CO2-RR and in situ Fourier transform infrared spectra on the surface of Bi2WO6 prove that V1 sites facilitate CH4 generation. Our work provides a strategy to obtain nonmetallic plasmonic materials by electron doping.

Self-Z-scheme plasmonic tungsten oxide nanowires for boosting ethanol dehydrogenation under UV-visible light irradiation.

Nonstoichiometric tungsten oxides (WO3-x) with abundant oxygen vacancies were synthesized and used as nonmetallic plasmonic photocatalysts to promote ethanol dehydrogenation under UV-visible light irradiation. Plasmonic WO3-x have unique electronic structures that act as Z-scheme heterostructures. UV-excited photoelectrons were injected into the conduction band of WO3-x, stabilizing the free electron density and boosting plasmonic hot electron generation for ethanol dehydrogenation. The synergetic effect of UV and visible light excitations greatly enhances the aldehyde generation to 2696 µmol g-1 (3 hours) with a high selectivity of 91%, which is 74-fold and 12-fold higher than those obtained under only UV or visible light irradiation, respectively.

Microfluidic Manufacturing of SN-38-Loaded Polymer Nanoparticles with Shear Processing Control of Drug Delivery Properties.

Two-phase gas-liquid microfluidic reactors provide shear processing control of SN-38-loaded polymer nanoparticles (SN-38-PNPs). We prepare SN-38-PNPs from the block copolymer poly(methyl caprolactone- co-caprolactone)- block-poly(ethylene oxides) (P(MCL- co-CL)- b-PEO) using bulk and microfluidic methods and at different drug-to-polymer loading ratios and on-chip flow rates. We show that, as the microfluidic flow rate ( Q) increases, encapsulation efficiency and drug loading increase and release half times increase. Slower SN-38 release is obtained at the highest Q value ( Q = 400 µL/min) than is achieved using a conventional bulk preparation method. For all SN-38-PNP formulations, we find a dominant population (by number) of nanosized particles (<50 nm) along with a small number of larger aggregates (>100 nm). As Q increases, the size of aggregates decreases through a minimum and then increases, attributed to a flow-variable competition of shear-induced particle breakup and shear-induced particle coalescence. IC25 and IC50 values of the various SN-38-PNPs against MCF-7 cells show strong flow rate dependencies that mirror trends in particle size. SN-38-PNPs manufactured on-chip at intermediate flow rates show both minimum particle sizes and maximum potencies with a significantly lower IC25 value than the bulk-prepared sample. Compared to conventional bulk methods, microfluidic shear processing in two-phase reactors provides controlled manufacturing routes for optimizing and improving the properties of SN-38 nanomedicines.

Synthesis, Self-Assembly, and Drug Delivery Characteristics of Poly(methyl caprolactone-co-caprolactone)-b-poly(ethylene oxide) Copolymers with Variable Compositions of Hydrophobic Blocks: Combining Chemistry and Microfluidic Processing for Polymeric Nanomedicines.

The synthesis, characterization, and self-assembly of a series of biocompatible poly(methyl caprolactone-co-caprolactone)-b-poly(ethylene oxide) amphiphilic block copolymers with variable MCL contents in the hydrophobic block are described. Self-assembly gives rise to polymeric nanoparticles (PNPs) with hydrophobic cores that decrease in crystallinity as the MCL content increases, and their morphologies and sizes show nonmonotonic trends with MCL content. PNPs loaded with the anticancer drug paclitaxel (PAX) give rise to in vitro PAX release rates and MCF-7 GI50 (50% growth inhibition concentration) values that decrease as the MCL content increases. We also show for selected copolymers that microfluidic manufacturing at a variable flow rate enables further control of PAX release rates and enhances MCF-7 antiproliferation potency. These results indicate that more effective and specific drug delivery PNPs are possible through tangential efforts combining polymer synthesis and microfluidic manufacturing.

Microfluidic Manufacturing of Polymeric Nanoparticles: Comparing Flow Control of Multiscale Structure in Single-Phase Staggered Herringbone and Two-Phase Reactors.

We compare the microfluidic manufacturing of polycaprolactone-block-poly(ethylene oxide) (PCL-b-PEO) nanoparticles (NPs) in a single-phase staggered herringbone (SHB) mixer and in a two-phase gas-liquid segmented mixer. NPs generated from two different copolymer compositions in both reactors and at three different flow rates, along with NPs generated using a conventional bulk method, are compared with respect to morphologies, dimensions, and internal crystallinities. Our work, the first direct comparison between alternate microfluidic NP synthesis methods, shows three key findings: (i) NP morphologies and dimensions produced in the bulk are different from those produced in a microfluidic mixer, whereas NP crystallinities produced in the bulk and in the SHB mixer are similar; (ii) NP morphologies, dimensions, and crystallinities produced in the single-phase SHB and two-phase mixers at the lowest flow rate are similar; and (iii) NP morphologies, dimensions, and crystallinities change with flow rate in the two-phase mixer but not in the single-phase SHB mixer. These findings provide new insights into the relative roles of mixing and shear in the formation and flow-directed processing of polymeric NPs in microfluidics, informing future reactor designs for manufacturing NPs of low polydispersity and controlled multiscale structure and function.

Multi-arm PEG/silica hydrogel for sustained ocular drug delivery.

In the present study, a series of sustained drug delivery multiarm poly(ethylene glycol) (PEG)/silica hydrogels were prepared and characterized. The hydrogels were formed by hydrolysis and condensation of poly(4-arm PEG silicate) using the sol-gel method. The relationships between water content in the PEG/silica hydrogel and stability as well as rheological properties were evaluated. Scanning electron microscopy analysis of the PEG/silica hydrogels revealed water content-dependent changes in microstructure. An increase in water content resulted in larger pores within the hydrogel, longer gelation time and higher viscosity. The PEG/silica hydrogels were loaded with dexamethasone (DMS) or dexamethasone sodium phosphate (DMSP), drugs that are hydrophobic and hydrophilic in nature, respectively. Evaluation of in vitro release revealed a zero-order release profile for DMS over the first 6 days, suggesting that degradation of the silica hydrogel matrix was the primary mechanism of drug release. It was also found that the drug-release profile could be tailored by varying the water content used during hydrogel preparation. In contrast, more than 90% of DMSP was released within 1 h, suggesting that DMSP release was only controlled by diffusion. Overall, results from this study indicate that PEG/silica hydrogels may be promising drug-eluting depot materials for the sustained delivery of hydrophobic, ophthalmic drugs.

Hydrogel containing silica shell cross-linked micelles for ocular drug delivery.

Poly(2-hydroxyethyl methacrylate-methacrylic acid-ethylene glycol dimethacrylate) hydrogels loaded with silica shell cross-linked methoxy(polyethylene glycol)-block-polycaprolactone (MePEG-b-PCL) micelles with rod-like morphology were prepared as a potential soft contact lens material for the sustained release of ocular drugs. The silica shell cross-linked methoxy micelles (SSCMs) comprising a polycaprolactone core surrounded by a silica shell were synthesized and their size, morphology, stability, and drug release kinetics were evaluated. The relationships between the composition of the SSCM-loaded poly(2-hydroxyethyl methacrylate) (pHEMA)-based hydrogels and their transparency, surface wettability, and equilibrium water content were determined. Scanning electron microscopy (SEM) images of SSCM-hydrogel systems showed the presence of intact SSCMs within the hydrogel matrix. Dexamethasone acetate (DMSA), a hydrophobic ophthalmic drug, was loaded into the SSCMs prior to their incorporation into the hydrogels. In vitro release of DMSA from the SSCM-hydrogels, with varying drug loading levels, was observed for up to 30 days. Overall, the incorporation of rod-like SSCMs within pHEMA-based hydrogels provided sustained release over prolonged periods while maintaining optical transparency. This delivery system may be suitable for use as a therapeutic soft contact lens material.

Hydrogels Containing Core Cross-Linked Block Co-Polymer Micelles.

Poly(2-hydroxyethyl methacrylate) (pHEMA) hydrogels loaded with core cross-linked PEG-b-PCL micelles with different morphologies (spherical and rod-like) were prepared and evaluated for use as drugeluting soft contact lenses. The relationship between the composition of micelle-loaded pHEMA hydrogels and properties such as transparency and swelling were determined. The incorporation of core crosslinked micelles into pHEMA hydrogels led to the formation of different internal nanostructures which were dependent on the amount and morphology of the micelles added. 7-Hydroxy-9H-(1,3-dichloro-9,9'-dimethylacridin-2-one) (DDAO), a hydrophobic fluorescent dye, was loaded into the micelles prior to their incorporation within the hydrogel matrix. The in vitro release of DDAO demonstrated the potential of the micelles/pHEMA hydrogels to provide controlled drug delivery for at least 14 days. This study demonstrates the feasibility of both chemical and physical incorporation of block co-polymer micelles within pHEMA hydrogels as a means to achieve sustained release of drugs for potential application in ophthalmic therapies.

Shell cross-linked and hepatocyte-targeting nanoparticles containing doxorubicin via acid-cleavable linkage.

Hepatocyte-targeting and shell cross-linked nanoparticles with lactose moiety on the surface and doxorubicin (DOX) in the core were prepared from lactose-PEG-DOX conjugate. The process consists of the synthesis of a novel α-hydrazine-ω-propargyl poly(ethylene glycol) (PEG) with a double bond in the PEG backbone, followed by the bonding of a lactose molecule containing an azide group to the ω-end of PEG via "click" chemistry, and finally, the conjugation of DOX to the α-end of PEG via an acid-labile, hydrazone linkage. The resultant conjugate can be self-assembled into nanoparticles. Thiolated tri(ethylene glycol) was introduced into the shell of nanoparticles as a cross-linking agent. The release of DOX is more rapid from lactose-PEG-DOX at pH 5.0 than at pH 7.4. Fluorescent microscope studies suggest that the lactose-DOX nanoparticles are internalized by hepatoma cells through a lactose receptor-mediated mechanism, whereas the lactose-free nanoparticles are not endocytosed as rapidly as lactose-DOX nanoparticles. MTT assay also shows that lactose-DOX nanoparticles have a stronger inhibition against hepatoma cells than DOX nanoparticles and pure DOX. FROM THE CLINICAL EDITOR: In this basic science study, a highly efficient targeted doxorubicin delivery method to hepatocytes is presented.

A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer.

A novel amphiphilic polymer-paclitaxel conjugate P(LGG-paclitaxel)-PEG-P(LGG-paclitaxel) has been prepared. It was derived from its parent polymer P(LGG)-PEG-P(LGG), poly{(lactic acid)-co-[(glycolic acid)-alt-(l-glutamic acid)]}-block-poly(ethylene glycol)-block-poly{(lactic acid)-co-[(glycolic acid)-alt-(l-glutamic acid)]}, which was prepared by ring-opening copolymerization of l-lactide (LLA) with (3s)-benzoxylcarbonylethyl-morpholine-2,5-dione (BEMD) in the presence of dihydroxyl PEG with molecular weight of 4600 as a macroinitiator using stannous octoate (Sn(Oct)(2)) as catalyst, and by subsequent catalytic hydrogenation. It could self-assemble into micelles in an aqueous system with P(LGG-paclitaxel) block in the core and PEG in the shell. ESEM and DLS analysis of the micelles revealed a homogeneous spherical morphology and a unimodal size distribution. In vitro release of paclitaxel from the conjugate micelles showed that its release rate depended on pH value and was higher at lower pH than in neutral condition. In vitro antitumor activity of the paclitaxel conjugate against rat brain glioma C6 cells was evaluated by MTT method. The results showed that the paclitaxel can be released from the conjugate without losing cytotoxicity.

Biodegradable amphiphilic triblock copolymer bearing pendant glucose residues: preparation and specific interaction with Concanavalin A molecules.

A novel biodegradable amphiphilic block copolymer PLGG-PEG-PLGG bearing pendant glucose residues is successfully prepared by the coupling reaction of 3-(2-aminoethylthio)propyl-alpha-D-glucopyranoside with the pendant carboxyl groups of PLGG-PEG-PLGG in the presence of N,N'-carbonyldiimidazole. The polymer PLGG-PEG-PLGG, i.e., poly{(lactic acid)-co-[(glycolic acid)-alt-(L-glutamic acid)]}-block-poly(ethylene glycol)-block- poly{(lactic acid)-co-[(glycolic acid)-alt-(L-glutamic acid)]}, is prepared by ring-opening copolymerization of L-lactide (LLA) with (3s)-benzoxylcarbonylethylmorpholine-2,5-dione (BEMD) in the presence of dihydroxyl PEG with molecular weight of 2000 as macroinitiator and Sn(Oct)2 as catalyst, and then by catalytic hydrogenation. The glucose-grafted copolymer shows a lower degree of cytotoxicity to ECV-304 cells and improved specific recognition and binding with Concanavalin A (Con A). Therefore, this kind of glucose-grafted copolymer may find biomedical applications.

Synthesis and characterization of novel biotinylated biodegradable poly(ethylene glycol)-b-poly(carbonate-lactic acid) copolymers.

Poly(ethylene glycol)-b-poly(5-benzyloxy-trimethylene carbonate-lactic acid) copolymers (PEG-b-P(BTMC-LA)) were synthesized by ring-opening polymerization of lactide and 5-benzyloxy trimethylene carbonate in the presence of mono-hydroxyl poly(ethylene glycol) with diethyl zinc as catalyst. They were further converted into deprotected copolymers with the pendant hydroxyl groups by hydrogenolysis in the presence of Pd(OH)2/C, and finally conjugated with biotin through the free hydroxyl groups. Gel permeation chromatography, Fourier transform infrared, differential scanning calorimetry and 1H nuclear magnetic resonance studies confirmed the copolymer structures and successful attachment of biotin to the copolymer.